IMS Acquires Semantelli, a Potential Big Data Booster Shot
Jinfo Article
7th May 2013
Abstract
Supplier of pharmaceutical trending information, IMS Health, has acquired social media analytics firm Semantelli. Victor Camlek examines the possibilities for big data analytics from the deal and the likely benefits for IMS customers.
Content Access
Access to Jinfo Content and Community is available through a Jinfo Subscription.
Does your organisation have a Jinfo Subscription?
"Not yet"
Access to this article is available through a Jinfo Subscription, which will help your organisation:
- Save time and money
- Re-invent information services
- Define, measure and communicate information value.
"Don't know"
Contact us to find out if your organisation already has a Jinfo Subscription.
Or use the 'Text Chat' button at the bottom-right of this page for immediate assistance.
- Article title: IMS Acquires Semantelli, a Potential Big Data Booster Shot
- Link to this page
- View printable version
Related articles:
- Has LinkedIn Got its Finger on the Pulse of its Contacts?
Wednesday, 1st May 2013 - The Importance of Context in Search and Big Data
Monday, 29th April 2013 - Elsevier Acquires Mendeley - Sell-out or Wise Move?
Monday, 15th April 2013
Related Blog items:
- Big Data... And the Information Professional
Friday, 3rd May 2013
Vendor adoption of AI
Community session
23rd May 2024
AI prompting and AI-sourcing, US private companies, and Jinfo on YouTube
Blog posting
10th April 2024
April 2024 Update
YouTube video
10th April 2024
- AI prompting and AI-sourcing, US private companies, and Jinfo on YouTube
10th April 2024 - AI practical actions, prompting and outsourcing
6th March 2024 - GenAI and ESG wisdom of the Jinfo crowd
13th February 2024
- Jinfo Community session (TBC) (Community) 16th July 2024
- Jinfo Community session (TBC) (Community) 20th June 2024
- Vendor adoption of AI (Community) 23rd May 2024